Neutrophilia has been identified as a predictor of poor outcomes in COVID-19 because severe disease is linked to an increased neutrophil-to-lymphocyte ratio and elevated expression of the neutrophil-related cytokines IL-8 and IL-6 in the serum [110,111]. This evidence concerns the gene IL6 and COVID-19.